Keyword
Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 SecondWave Systems secures over $7 Million from Department of Defense to Accelerate Development and Clinical Study of Novel Anti-Inflammatory Therapy based on Low-Intensity Focused Ultrasound Technology
2 Using ultrasound stimulation to reduce inflammation in COVID-19 in-patients
3 INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800
4 PhysIQ, Department of Defense, Duke University, Johns Hopkins and HJF Partner to Study COVID-19
5 Fact Check: Military-funded sensor can help detect COVID-19, but it's not a microchip
6 MCSC supports Air Force-led effort to safely transport COVID-19 patients
7 Phase 2 trial data shows INOVIO COVID-19 vaccine effective and well-tolerated in all age groups
8 DARPA Selects Teams to Defend Against Chemical, Biological Threats from Inside and Out
9 Biological E. to begin Phase III Covid-19 vaccine candidate trial
10 INOVIO to Present at Upcoming Investor Conferences in May
11 Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing
12 Inovio To Conduct Phase-3 Trials Of COVID-19 Vaccine Outside the US As US Govt Stops Funding
13 News
14 Can Inovio Recover From Its Huge Setback?
15 Chem-Bio Defense Office Reorganizes to Take on New Threats
16 Pre-Open Stock Movers 04/23: (SYPR) (SLAB) (EBSB) Higher; (INO) (QDEL) (EDAP) Lower (more...)
17 JPM CBRN Medical Tiger Team Takes Bold Action to Support Pandemic Response
18 Inovio's Covid-19 vaccine studies just hit a brick wall at the Pentagon. Are other hopefuls in trouble?
19 Partner Therapeutics Initiates Patient Enrollment in Clinical Trial Evaluating Leukine® (rhuGM-CSF, sargramostim) in High-risk Non-hospitalized COVID-19 Patients (SCOPE)
20 Increased Collaboration Promotes Improved Medical Diagnostic Capabilities and Health Outcomes
21 Inovio Pharmaceuticals: Once Bitten, Twice Shy
22 Quantum Leap Healthcare Collaborative Concludes Cenicriviroc Not Likely to Reduce Time to Recovery or Mortality in Critically Ill Patients in I-SPY COVID Trial
23 Rigel Reports First Quarter 2021 Financial Results and Provides Business Update
24 Pfizer-BioNTech, Moderna Vaccines Effective Against Variants and More COVID-19 News
25 JPEO-CBRND Works with Industry to Develop COVID-19 Diagnostic Tests
26 Global Biodefense market is expected to reach US$ 8350.74 Mn in 2027 from US$ 4108.24 Mn in 2019 Dynavax Technologies, Elusys Therapeutics, Inc., Soligenix, Altimmune, Pluristem Therapeutics – The Courier
27 ASA(ALT) AT WORK: JPEO-CBRND PROFILE
28 SAB Biotherapeutics Doses First Patient with SAB-185 for the Treatment of COVID-19 in NIH's ACTIV-2 Phase 2/3 Clinical Trial
29 Chem-Bio Defense Program Eases Path for Industry
30 The Week That Will Be
31 A sensor injected under the skin, backed by DARPA, is meant to spot COVID-19 days before symptoms appear
32 INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to Treat COVID-19 with Funding from the Defense Advanced Research Projects Agency (DARPA) and the Department of Defense's (DoD) Joint Program Executive Office for C
33 News
34 Humanigen signs Covid-19 therapy development deal with US
35 DARPA, JPEO-CBRND funds target COVID-19 treatment development
36 The US Government Hides Some Of Its Darkest Secrets At The Department Of Energy
37 Next Post: President Biden Announces 16 Key Administration Nominations
38 Noblis Gets a DHS Contract to Protect US Against WMDs
39 JPEO-CBD Activates New Joint Project Management Office of Medical Countermeasure Systems (MCS)
40 DOD OTA AGREEMENT LEVERAGED BY INTERAGENCY FOR COVID-19 RAPID RESPONSE
41 CCDC Chemical Biological Center's Mobile Lab Expertise Enables Readiness
42 Joint Services CBRND Office Realigns To Focus On Protection, Sensors And Medical
43 US Department of Defense selects Pharm-Olam as CRO for Adalimumab COVID Therapeutic Trial
44 HHS, DoD Ink $1.5B Deal With Moderna for COVID-19 Vaccine Production
45 FLIR Receives Additional $26M Contract for U.S. Army's Nuclear, Biological and Chemical Reconnaissance Vehicle Program
46 Alion to Support U.S. Chemical, Biological, and Nuclear Defense
47 JUPITR program takes shape on Korean Peninsula | Article | The United States Army
48 Novavax Awarded Department of Defense Contract for COVID-19
49 Immunome discovers spike/nonspike SARS-CoV-2 antibodies
50 Pharm-Olam to support Adalimumab COVID Therapeutic Trial
51 Army fields new chemical detection technology
52 PhysIQ, Department of Defense, and The Henry M. Jackson Foundation for the Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19
53 Just
54 Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent's COVID
55 Defense Officials See Increased Threat from Chinese Russian ChemBio Weapon
56 Militarizing Global Health Isn't the Right Answer
57 News
58 DHS Awards LMI Prime Contract to Support Countering Weapons of Mass Destruction Office – Homeland Security Today
59 Humanigen gains BARDA access to produce lenzilumab for treating Covid-19
60 SAB Biotherapeutics Awarded $35.6M from U.S. Department of Defense for COVID-19 and Scaling Rapid Response Antibody Program
61 U.S. Government Issues RFI for Solutions to Combat Coronavirus (COVID-19)
62 Just, Evotec Expand MAbs Manufacturing Contract With DOD
63 Latest sensor upgrades boost recon vehicle capabilities | Article | The United States Army
64 Defense Watch: Fielding M-SHORAD, Taiclet on Space Biz, UK Air Chief
65 Sorrento Receives $34M Federal Contract for Covid Treatment
66 HHS, DOD Sign $3.65B in COVID-19 Vaccine Deals With Pfizer-BioNTech, Moderna
67 Collaboration Made NBCRV's Sensor Suite Upgrade Possible
68 DTRA Side-Steps COVID Challenges to Continue Support to International Partners
69 SAB Biotherapeutics Awarded $57.5M from BARDA and U.S. Department of Defense for Manufacturing of SAB-185 for the Treatment of COVID-19
70 Rigel Awarded $16.5 Million from US Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
71 Evotec Subsidiary Expands mAb Contract with the U.S. DOD
72 Ology Bioservices to Adapt Veroplex® Cell Platform for Rapid Response to Viral Threats for Department of Defense
73 Technology Demonstration Shows Air Force Can Maintain Mission Effectiveness in CBRN Environment
74 INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the US Department of Defense
75 MRIGlobal To Deliver Three Mobile Medical Labs For Department Of Defense
76 Coronavirus Pandemic Solutions Sought by Government
77 Urgent Acquisition Effort Provides Safe COVID-19 Patient Transport in 95 Days
78 Humanigen Announces Cooperative Research and Development Agreement with the Department of Defense to Develop Lenzilumab for COVID-19
79 LMI Secures $78M Contract to Support DHS Counter-WMD Mission; John Selman Quoted
80 DOD taps Pharm-Olam for repurposed Humira COVID-19 test
81 SIGA Technologies Announces Department of Defense Increases
82 $37.6M grant awarded to develop innovative COVID-19 treatment
83 AZD1222 US Phase III Primary Analysis Confirms Safety and Efficacy
84 Global CBRN Market and Technology Forecast to 2028
85 DOD experts explain: The science behind the COVID-19 vaccines
86 Mount Sinai, Emergent, And ImmunoTek Form Collaboration
87 Cue Health Receives $481M From DoD to Expand COVID-19 Testing Capacity
88 Inovio to begin Phase II segment of Covid-19 vaccine trial
89 Corning Announces Expansion of Contract with US
90 Feds order 200M more vaccine doses from Pfizer, Moderna
91 908 Devices Gets $11.5M to Create New Device with the Defense Threat Reduction Agency
92 Commercial healthcare drone delivery service in North Carolina, USA
93 AFICC increases COVID-19 testing capabilities at 42 medical centers
94 SiO2 Materials Science Receives $143 Million Contract from U.S. Government to Accelerate Capacity Scale-Up of Advanced Primary Packaging Platform for COVID-19 Vaccines and Therapeutics
95 Ready For Action: Enhancements Completed On US Army's State-Of-The-Art Chemical Defense Training Facility (CDTF) At Fort Leonard Wood
96 Abzena Selected by Immunome to Develop and Manufacture Antibody Cocktail for Immunome's COVID-19 Antibody Based Treatment
97 U.S. Army awards new contract to FLIR for NBCRV program
98 Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for Prophylaxis
99 Army Issues $25M Sole-Source Contract to Monitor COVID-19 Vaccine Temperatures
100 Army Experts Help DHS Develop Standoff Chemical Detection Capability